Lars Hellgren

Dr. Lars Hellgren


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
AAAndreas Artmann
Andreas Artmann
GPGitte Petersen
Gitte Petersen
LHLars Hellgren
Lars Hellgren
JBJulie Boberg
Julie Boberg
CSChristian Skonberg
Christian Skonberg
HHHarald S. Hansen
Harald S. Hansen

1 June 2010 in Allergy
Verified
Journal Article
Closed access
PDF file
JJJ. M. Jungersted
J. M. Jungersted
HSH. Scheer
H. Scheer
MMM. Mempel
M. Mempel
HBHansjörg Baurecht
Hansjörg Baurecht
LCL. Cifuentes
L. Cifuentes
SWS. Weidinger
S. Weidinger

1 November 2010 in Food Chemistry
Verified
Journal Article
Closed access
BLBena-Marie Lue
Bena-Marie Lue
NNNina Skall Nielsen
Nina Skall Nielsen
Charlotte JacobsenCharlotte Jacobsen
Charlotte Jacobsen
LHLars Hellgren
Lars Hellgren
ZGZheng Guo
Zheng Guo
XXXuebing Xu
Xuebing Xu

14 April 2008 in Contact Dermatitis
Verified
Journal Article
Open access
PDF file
JJJakob Mutanu Jungersted
Jakob Mutanu Jungersted
LHLars Hellgren
Lars Hellgren
GJGregor B. E. Jemec
Gregor B. E. Jemec
TATove Agner
Tove Agner
The stratum corneum (SC) protects us from dehydration and external dangers. Much is known about the morphology of the SC and penetration of drugs through it, but the data are mainly derived from in vitro and animal experiments. In contrast, only a few studies have the human SC lipids as their focus and in particular, the role of barrier function in the pathogenesis of skin disease and its subsequent treatment protocols. The 3 major lipids in the SC of importance are ceramides, free fatty acids, and cholesterol. Human studies comparing levels of the major SC lipids in patients with atopic dermatitis and healthy controls have suggested a possible role for ceramide 1 and to some extent ceramide 3 in the pathogenesis of the disease. Therapies used in diseases involving barrier disruption have been sparely investigated from a lipid perspective. It has been suggested that ultraviolet light as a treatment increases the amount of all 3 major SC lipids, while topical glucocorticoids may lead to a decrease. Such effects may influence the clinical outcome of treatment in diseases with impaired barrier function. We have, therefore, conducted a review of the literature on SC lipids from a clinical perspective. It may be concluded that the number of human studies is very limited, and in the perspective of how important diseases of impaired barrier function are in dermatology, further research is needed.

4 October 2009 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
HTHenrik Tjellström
Henrik Tjellström
LHLars Hellgren
Lars Hellgren
ÅWÅke Wieslander
Åke Wieslander
ASAnna Stina Sandelius
Anna Stina Sandelius
As in other eukaryotes, plant plasma membranes contain sphingolipids, phospholipids, and free sterols. In addition, plant plasma membranes also contain sterol derivatives and usually 5 mol% DGDG was included. As both the apoplastic plasma membrane leaflet (probably the major water permeability barrier) and rafts both contain only trace amounts of DGDG, we conclude that this lipid class is not compatible with membrane functions requiring a high degree of lipid order. By not replacing phospholipids site specifically with DGDG, negative functional effects of this lipid in the plasma membrane are avoided.—Tjellstrom, H., Hellgren, L. I., Wieslander, A., Sandelius, A. S. Lipid asymmetry in plant plasma membranes: phosphate deficiency‐induced phospholipid replacement is restricted to the cytosolic leaflet. FASEB J. 24, 1128–1138 (2010). www.fasebj.org

1 June 2013 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
LHLaurine Bs Harsløf
Laurine Bs Harsløf
LLLesli H Larsen
Lesli H Larsen
CRChristian Ritz
Christian Ritz
LHLars Hellgren
Lars Hellgren
KMKim Fleischer Michaelsen
Kim Fleischer Michaelsen
LLLotte Lauritzen
Lotte Lauritzen
Background: Infant docosahexaenoic acid (DHA) status is supported by the DHA content of breast milk and thus can decrease once complementary feeding begins. Furthermore, it is unclear to what extent endogenous DHA synthesis contributes to status.